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Abstract
Background: Limited availability of skilled health providers in developing countries is thought to be an important
barrier to achieving maternal and child health-related MDG goals. Little is known, however, about the extent to
which scaling-up supply of health providers will lead to improved pregnancy and birth outcomes. We study the
effects of the Midwives Service Scheme (MSS), a public sector program in Nigeria that increased the supply of
skilled midwives in rural communities on pregnancy and birth outcomes.
Methods: We surveyed 7,104 women with a birth within the preceding five years across 12 states in Nigeria and
compared changes in birth outcomes in MSS communities to changes in non-MSS communities over the same
period.
Results: The main measured effect of the scheme was a 7.3-percentage point increase in antenatal care use in
program clinics and a 5-percentage point increase in overall use of antenatal care, both within the first year of the
program. We found no statistically significant effect of the scheme on skilled birth attendance or on maternal
delivery complications.
Conclusion: This study highlights the complexity of improving maternal and child health outcomes in developing
countries, and shows that scaling up supply of midwives may not be sufficient on its own.
Keywords: Health workers, Midwives, Supply, Maternal health, Impact evaluation
Abbreviations: DID, Difference-in-difference; GPS, Global positioning system; MDG, Millennium development goals;
MSS, Midwives service scheme; NPHCDA, National primary health care development agency
Background
One of the major global health challenges of the 21st
century is reducing the approximately 3 million newborn
deaths, 7 million under-five deaths, and 300,000 mater-
nal deaths that occur globally each year. This health bur-
den is not uniformly distributed: most deaths occur in
the poorest regions of the world—87 % of maternal
deaths and about 65 % of neonatal deaths, for example,
occur in sub-Saharan Africa and South Asia [1]. Many of
these deaths are believed to be preventable: it has been esti-
mated, for example, that up to a third of maternal deaths,
and half of newborn deaths can be prevented by increasing
coverage rates for skilled attendance at delivery [2–4].
In many of the countries lagging behind Millennium
Development Goal (MDG)-related targets, poor access
to skilled health providers, particularly in rural areas, is
regarded as one of the main challenges to increasing
rates of skilled birth attendance and improving out-
comes for children and mothers [5]. Two recent studies
have brought this issue into sharp focus by estimating
the effect of scaling up access to midwives on maternal
and infant health [6, 7]. Given limited empirical evidence
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regarding the effects of scaling up access to midwives,
both studies rely on model-based projections.
In this paper, we present empirical findings from an
evaluation of a large-scale program in Nigeria that sought
to increase access to midwives in rural communities. This
program, known as the Midwives Service Scheme, de-
ployed thousands of midwives to primary health facilities
across Nigeria to increase access to skilled care. The stated
goal of the program was to double the proportion of births
attended by skilled attendants by December 2015. In 2014
we carried out a mixed-methods evaluation to study the
impact of the program on use of antenatal care during
pregnancy and on skilled birth attendance five years after
implementation of the scheme. We also examine effects
on maternal delivery complications. This study provides
timely evidence to policy makers in developing countries
looking to increase coverage of skilled birth attendance
and improve maternal and child health outcomes.
Methods
The Nigerian midwives service scheme
Every year, more than 50,000 Nigerian women die from
pregnancy-related complications. The chance of a woman
dying during pregnancy and childbirth in Nigeria is ap-
proximately 1 in 30 compared to about 1 in 2,400 in devel-
oped countries [8]. Infants also experience poor health
outcomes with an estimated 250,000 newborn deaths an-
nually. These high rates of mortality have been attributed
in part to low utilization of pregnancy and delivery care:
only 39 % of births, for example, are attended by a skilled
health provider. In many health facilities across the coun-
try, there is a shortage of skilled providers (doctors, nurses
and midwives). A survey of primary health facilities in
rural communities found that up to half did not have a
single midwife [9].
The Midwives Service Scheme (MSS) was introduced in
December 2009 to address these challenges. The key fea-
ture of the MSS was the recruitment and deployment of
unemployed, retired, and newly graduating midwives to
government primary health facilities in rural and under-
served communities. Participating midwives were recruited
through a national recruitment exercise. The scheme was
funded by debt relief funds under a 2009 Appropriations
Act and was designed to be a collaborative effort between
all three tiers of government. The federal government re-
cruited and deployed the midwives, paid them a monthly
salary (N30,000 or approximately 150 USD) and supplied
clinics with midwifery kits (these kits contain essential
items needed for deliveries such as instruments, sutures,
gloves, and cord clamps), basic equipment such as blood
pressure apparatus and weighing scales, some essential
drugs, and facility/community registers for record keep-
ing; state governments paid additional allowances to mid-
wives (N20,000 per month) and provided monitoring and
supervision; local governments paid a supplementary al-
lowance of N10,000 and provided free accommodation for
the midwives in the local community.
The first phase of the scheme—the subject of our eva-
luation—rolled out nationally in 652 primary health care
facilities in 2009. The distribution of MSS facilities was
determined largely by geographic location. States in the
northeast and northwest zones (classified as ‘very high’
maternal mortality zones) were assigned 24 facilities
each, states in the north-central and south-south (classi-
fied as ‘high’ mortality zones) were assigned 16 facilities
each, and states in the southwest and southeast (classi-
fied as ‘moderate’ mortality zones) were assigned 12 fa-
cilities each (see Table 1). Each MSS facility was linked
to a general hospital that would serve as a referral hos-
pital. Nearly 2,500 midwives in total were deployed in
the first phase of the scheme.
Study design
To identify the effects of the MSS we compared changes
in pregnancy and birth outcomes in MSS (intervention)
communities to changes in non-MSS (comparison) com-
munities in the same states over the same period i.e., a
difference-in-difference design. The comparison group
consisted of similar communities (as the intervention com-
munities) that, however, were not enrolled in (an updated
version of) the program until three years later; we refer to
this as Wave 2. Thus we exploit the fact that there was a
window of time within which one group of communities
was exposed (Wave 1) but the other was not yet exposed
(Wave 2). Both sets of health facilities were selected using
the same criteria. Data on pregnancy and birth outcomes
were collected retrospectively through a household survey
in both sets of communities targeting women who had a
recent pregnancy (see next section). A graphical illustration
of our study design is provided in Fig. 1.
Two hundred eight MSS communities were randomly se-
lected to participate in the study. To draw the study sample
we began by randomly selecting two states in each geopolit-
ical zone (making 12 states in total), and then enrolling all
MSS health facilities in the state into the study. We ran-
domly selected an equivalent number of Wave 2 facilities in
each state to serve as a comparison group. It is important
to clarify that prior to rollout, participating communities
Table 1 Distribution of health facilities
Region Number of states/region Number of clinics/state
North-East 6 24
North-West 7 24
North-Central 7 16
South-South 6 16
South-East 5 12
South-West 6 12
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did not have any advance knowledge that they would par-
ticipate in the scheme. We carried out qualitative interviews
and focus groups in three purposively selected states to
shed light on program implementation and to provide add-
itional context for the evaluation findings. These results are
presented in a companion paper [10].
Data collection
Institutional Review Boards at RAND, Bayero University
Kano, and University of Nigeria Enugu provided ethical
review and approval for the study. Data collection took
place between June 2014 and January 2015. Since a com-
prehensive listing of households in each community was
unavailable, we randomly generated Global Positioning
System (GPS) coordinates within each community using
a GPS-enabled tablet and special software and selected
the dwelling nearest this point for interview. Twenty
households were randomly selected in each community,
with the criterion for inclusion that they contained a
woman who was pregnant at least once between January
2009 and the date of interview. If there was no eligible
household within the dwelling, the interviewer visited the
dwelling on either side until one was found. If there were
multiple eligible households within the dwelling, one was
randomly chosen for interview. All eligible women within
each selected household were interviewed. To obtain con-
sent, interviewers read out a statement to study respon-
dents describing the study and any associated risks/benefits
of participation. Interviewers checked a box on the consent
screen of the tablet to indicate that verbal consent had
been provided. In total we interviewed 7,104 women in
368 communities (not all communities selected could be
surveyed because of logistical constraints).
The survey instrument included a household module
that collected information including dwelling character-
istics, source of drinking water, toilet facilities and
possession of various assets (these were aggregated into
a wealth index using principal component analysis); and
an individual module administered to all eligible women.
The individual module collected retrospective information
about each birth since January 2009 including use of ante-
natal and postnatal care, place of delivery, and pregnancy
and delivery complications such as haemorrhage, fever and
convulsions. Respondents were asked about complications
during delivery (intrapartum complications) and within six
weeks after delivery (postpartum complications). We also
carried out a clinic survey in each study clinic (both MSS
and non-MSS clinics). Interviewers collected data on clinic
characteristics including staffing and availability of supplies
from the officer-in-charge (or another knowledgeable indi-
vidual if the officer-in-charge was unavailable). All inter-
views were administered face-to-face using Android tablets.
key variables
Our primary outcomes are antenatal care and skilled birth
attendance. We consider the following measures for ante-
natal care: (1) an indicator for any antenatal care use, (2)
an indicator for whether a mother received at least 4 ante-
natal visits (per World Health Organization recommenda-
tions), and (3) an indicator for antenatal care obtained in
the study clinic. For skilled birth attendance our measures
are: (1) an indicator for whether a birth took place in the
study clinic, (2) an indicator for whether the birth took
place in any health facility (i.e., was attended), and (3) an
indicator for whether a birth was attended by a doctor,
nurse or midwife independent of birth location. For both
outcomes we look separately at uptake in the study clinic
and overall uptake. This allows us to measure any substitu-
tion effects i.e., women switching from other sources of
formal care to the MSS clinic. Even though the goal of the
program was to increase uptake among prior non-users,
switching from other sources of formal care to the MSS
Fig. 1 Graphical illustration of research design
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clinic is potentially beneficial if the MSS clinic is closer,
thus reducing time and travel costs, and/or if the care of-
fered by MSS midwives is of higher quality relative to
existing alternatives.
Our secondary outcomes are maternal birth complica-
tions. We look at the probability that a mother experienced
at least one of several complications including severe bleed-
ing, convulsions, retained placenta, prolonged labor, loss of
consciousness or high fever, either during the delivery
(intrapartum complications) or within six weeks of de-
livery (postpartum complications).
Empirical strategy
To identify the impact of the MSS, we estimate difference-
in-difference (DID) models that examine the relative change
in outcomes in MSS (intervention) relative to non-MSS
(comparison) areas. The basic econometric specification is
the following:
yijt ¼ αþ β1Treatedj þ β2Postt þ β3Treatedj  Postt þ ηj þ eijt
ð1Þ
yijt denotes the outcome of interest for birth i in com-
munity j in month t (starting in January 2009); Treatedjt
is an indicator that takes the value 1 if the study clinic in
community j is a Wave 1 (MSS) clinic; Postt is a binary
indicator that takes the value 1 after the MSS is intro-
duced; ηj is a community fixed effect; and eijt is an unob-
served error term. In this specification our interest
centers on the coefficient β3, which measures the differ-
ential change in the outcome in intervention communi-
ties relative to comparison communities. We include
controls for gender of the baby, an indicator for a mul-
tiple birth, marital status, mother’s education and reli-
gion, the mother’s age at the time of the birth, an
indicator equal to one if the woman reported at least
one complication during pregnancy, and household
wealth (quintiles of an asset-based wealth index derived
using principal component analysis). Standard errors are
clustered at the level of the community given correlation
in the outcomes within this level.
The main assumption required for identifying causal
effects in the DID model is that the evolution of out-
comes in intervention areas would have followed the
same pattern as in comparison areas in the absence of
the treatment (this is known as the parallel trends as-
sumption). While this counterfactual cannot be known,
we can test whether this assumption holds for each of
the outcome variables of interest prior to the introduc-
tion of the program. Finding that the trends are the
same in intervention and control areas before the pro-
gram adds to confidence in the assumption that (non-
program) trends are the same following program
introduction as well. We estimate the following regres-
sion specification:
yijt ¼ αþ βTreatedj þ γt þ δTreatedj  t þ ηj þ eijt ð2Þ
where the regression sample is restricted to baseline births
(those that occurred before introduction of the MSS), t de-
notes monthly pre-trends, and where interest centers on
the interaction coefficient δ (the parallel trends assump-
tion implies that δ = 0).
Results
All data were analyzed using Stata 12 software. The sur-
vey sample consists of 9,475 births born to 7,104 women
over the period 2009–2014, of which 4,746 (50.33 %) oc-
curred in MSS (intervention) areas. We exclude births
occurring after women in the comparison group became
exposed to the intervention, leaving us with 5,295 births
taking place between January 2009 and May 2012. Table 2
summarizes the variables used in the analysis at baseline,
and tests for balance across intervention and comparison
areas. Even though the DID identification strategy does
not require it (as noted earlier, the key assumption in-
volves equivalence of trends not levels), it is reassuring to
note that the outcome variables as well as the covariates
are relatively well balanced at baseline. In Table 3, we test
the parallel trends assumption for each of the outcome
variables of interest, using the specification shown in (2).
As Table 3 shows, the null hypothesis cannot be rejected
for any of the outcome variables, which lends credence to
the empirical strategy.
Table 4 presents the DID results for each of the mea-
sures of antenatal care. For each outcome, we report the
average effect of the MSS [this is the coefficient on the
interaction of Treated and Post from specification (1)].
We then disaggregate this average effect into effects in
each year of the program to examine whether the effects
of the scheme vary over time. The impact of the scheme
might increase over time if it takes time for information
about midwife availability in the clinic to spread through
the community or if it takes time to gain the trust of the
community. Conversely it might decrease if over time
the availability of midwives in the clinic becomes com-
promised. We present effects for Year 1, Year 2, and
Year 3 of the program after which the comparison group
becomes exposed.
The average effect in Table 4 indicates a small positive
impact of the program on antenatal care although this
result is not statistically significant. We see, however,
that this average effect obscures significant variation
over time. Row 2 indicates that the rate of antenatal care
usage at MSS clinics increased by about 7.3 percentage
points (CI: 0.3 to 14.2 %) in the first year of the program
(starting from a baseline rate of 62.2 %), but thereafter
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we are not able to find any program effect. There is a less
precisely estimated 5-percentage point increase (CI: −0.2
to 10.2 %) in the overall rate of antenatal care use, but lit-
tle evidence of an increase in the number of visits as mea-
sured by the rate of four or more antenatal visits.
In Fig. 2, we plot the coefficients (and associated 95 %
confidence intervals) from a more refined specification
that allows program effects to vary by quarter. We find
that antenatal care usage at the study clinic rose by more
than 10%age points in the first three quarters following
introduction of MSS, but thereafter dropped off. The
graphs also show that overall use of antenatal care (not
restricting to care in the study clinic) increased on both
Table 3 Testing for differential pre-trends in outcome variables
Number δ (95 % CI) p-value
Antenatal care in study clinic 1094 0.002 (−0.020, 0.025) 0.854
Any antenatal care 1091 0.009 (−0.011, 0.029) 0.371
4+ antenatal visits 1094 0.003 (−0.021, 0.028) 0.783
Delivery in study clinic 1094 0.004 (−0.019, 0.026) 0.761
Institutional delivery 1094 0.005 (−0.018, 0.028) 0.684
Skilled birth attendance 1094 −0.001 (−0.023, 0.021) 0.916
Intra-partum complications 1094 0.014 (−0.004, 0.032) 0.126
Post-partum complications 1094 0.008 (−0.005, 0.021) 0.213
δ denotes the differential linear trend in intervention communities relative to
comparison communities over the period prior to the start of the MSS. The
regression specification controls for community fixed effects. Standard errors
in parentheses are clustered at the community level
Table 4 Estimated effects of MSS on antenatal care utilization
Number β (95 % CI) p-value %D
Antenatal care in study clinic
Average effect 5295 0.023 (−0.038,0.084) 0.459 0.037
Year 1 5295 0.073** (0.003,0.142) 0.042 0.117
Year 2 5295 −0.007 (−0.078, 0.063) 0.838 −0.011
Year 3 5295 0.003 (−0.076, 0.082) 0.940 0.005
Any antenatal care
Average effect 5287 0.018 (−0.025, 0.061) 0.416 0.022
Year 1 5287 0.050* (−0.002,0.102) 0.059 0.060
Year 2 5287 −0.005 (−0.056, 0.045) 0.835 −0.006
Year 3 5287 0.009 (−0.047, 0.064) 0.763 0.011
4+ antenatal visits
Average effect 5295 −0.006 (−0.075, 0.062) 0.857 −0.012
Year 1 5295 0.028 (−0.047, 0.104) 0.463 0.055
Year 2 5295 −0.036 (−0.119, 0.048) 0.402 −0.071
Year 3 5295 −0.011 (−0.101, 0.080) 0.815 −0.022
β denotes the estimated effect of the MSS program, and is obtained using a
differences-in-differences specification that includes month of birth and
community fixed effects and controls for maternal and child characteristics. %D
expresses the estimated program effect as a percentage of the baseline average
of the outcome variable. Standard errors in parentheses are clustered at the
community level
**p < 0.05, *p < 0.1
Table 2 Baseline characteristics and balance
Control Intervention
Mean Std dev Mean Std dev p-value
Any antenatal care 0.801 0.400 0.834 0.372 0.281
4+ antenatal visits 0.504 0.500 0.506 0.500 0.953
Antenatal care in study clinic 0.539 0.499 0.622 0.485 0.054
Intra-partum complications 0.064 0.301 0.048 0.240 0.349
Post-partum complications 0.044 0.233 0.042 0.228 0.870
Institutional delivery 0.541 0.499 0.570 0.496 0.496
Delivered in study clinic 0.344 0.475 0.420 0.494 0.058
Skilled birth attendance 0.533 0.499 0.540 0.499 0.876
Breastfed for 6 months 0.417 0.493 0.376 0.485 0.342
Married 0.869 0.338 0.876 0.329 0.761
Age of mother 31.79 40.70 29.31 6.598 0.172
Illiterate 0.542 0.499 0.564 0.496 0.649
Muslim 0.591 0.492 0.574 0.495 0.773
Wealth index 2.934 1.468 2.936 1.431 0.989
Male child 0.512 0.500 0.532 0.499 0.503
Multiple birth 0.029 0.168 0.024 0.153 0.724
Low risk (no problems during pregnancy) 0.828 0.378 0.833 0.374 0.870
Note: p-values correspond to tests for differences in means, and allow for observations to be correlated within communities
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the extensive (i.e. rate of any antenatal care) and inten-
sive margins (rate of four or more antenatal visits) dur-
ing this period, but thereafter declined. From this we
conclude that the MSS had a significant, but somewhat
short-lived, impact on antenatal care use.
Table 5 presents the DID results for each of the mea-
sures of skilled birth attendance. Again we report aver-
age effects and effects over time. Overall, the MSS
appears to have had little impact on delivery in the study
clinic (Estimate: −0.7 %; CI: −7.0 to 5.5 %), institutional
delivery (Estimate: −1.6 %; CI: −7.4 to 4.1 %), or skilled
birth attendance (Estimate: −0.16 %; CI: −5.6 to 5.5 %).
The confidence intervals are tight enough that we can rule
out economically significant effects on any of the out-
comes. This conclusion is not significantly modified if we
decompose program effects by year or quarter (see Fig. 3).
In Table 6 we examine the impact of the MSS on our
secondary outcome, maternal complications. Not surpris-
ingly given the lack of major impacts on antenatal care or
birth attendance, we find no evidence that the MSS re-
duced the incidence of intrapartum complications (Esti-
mate: 1.2 %; CI: −2.8 to 5.1 %) or postpartum complications
(Estimate: 0.2 %; CI: −3.3 to 3.8 %).
Discussion
The results in the previous section show that the MSS had
smaller than anticipated effects (relative to the ambitious
program goals). The main measured effect of the program
is that it increased the use of antenatal care, with gains
concentrated in the first year of the program. The pattern
of results indicate that the MSS did not simply result in
women changing where they attended antenatal care, as
would have been the case if antenatal care use at the study
clinic increased without an increase in the overall rate of
antenatal care use. Given that the overall rate of antenatal
care use increased, albeit by a smaller fraction than the
observed increase in the MSS clinics, we conclude that
the MSS was successful in inducing some women into
antenatal care who would not have used care otherwise.
However, we find no evidence of an increase in institu-
tional deliveries or skilled birth attendance, even though
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Fig. 2 Program effects over time: Antenatal care
Table 5 Estimated effects of MSS on institutional delivery and
skilled birth attendance
Number β (95 % CI) p-value %D
Delivery in study clinic
Average effect 5295 −0.007 (−0.070, 0.055) 0.815 −0.017
Year 1 5295 −0.008 (−0.081, 0.065) 0.833 −0.019
Year 2 5295 0.005 (−0.067, 0.078) 0.883 0.012
Year 3 5295 −0.022 (−0.099, 0.055) 0.567 −0.052
Institutional delivery
Average effect 5295 −0.016 (−0.074, 0.041) 0.574 −0.028
Year 1 5295 −0.035 (−0.104, 0.035) 0.331 −0.061
Year 2 5295 0.000 (−0.066, 0.066) 0.991 0.000
Year 3 5295 −0.016 (−0.085, 0.053) 0.657 −0.028
Skilled birth attendance
Average effect 5295 −0.000 (−0.056, 0.055) 0.987 0.000
Year 1 5295 −0.014 (−0.081, 0.054) 0.686 −0.026
Year 2 5295 0.025 (−0.041, 0.090) 0.458 0.046
Year 3 5295 −0.015 (−0.084, 0.053) 0.665 −0.028
β denotes the estimated effect of the MSS program, and is obtained using a
differences-in-differences specification that includes month of birth and
community fixed effects and controls for maternal and child characteristics. %D
expresses the estimated program effect as a percentage of the baseline average
of the outcome variable. Standard errors in parentheses are clustered at the
community level
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this was the primary objective of the scheme. Our confi-
dence intervals allow us to rule out effects larger than
about 5.5 percentage points (or about 10 percent of the
baseline mean).
The fact that there were some positive impacts at the
beginning of the scheme that appeared to erode over
time may indicate that the effectiveness of the program
was compromised by operational challenges that
emerged over time. An in-depth look at the implementa-
tion of the scheme [10], indicates that problems such as
irregular payment of midwife salaries, and inadequate
provision of accommodation, affected availability of mid-
wives in the clinics and contributed to long-run difficul-
ties in retaining midwives in the scheme. However this
does not explain why there was no effect on skilled birth
attendance, even in the first year of the program. Our
data suggest that part of the reason for this is that other
dimensions of service quality did not improve, which de-
terred uptake [10]. For example, data from the clinic
survey suggest that clinic infrastructure in many cases
remained poor, as did availability of drugs and supplies.
Only 44 % of facilities visited received a rating of “good”
by project staff regarding the physical condition of the
building [options were poor (requires major rehabilita-
tion), fair (requires minor rehabilitation), and good (re-
quires no rehabilitation)]. Lack of electricity and water
were also problems: 35 % of MSS clinics in the clinic sur-
vey reported having no electricity. Availability of essential
medicines and basic equipment was poor. We assigned
clinics a score of one for each piece of equipment that was
functional, zero if not. The median score was 13 out of 22.
With regards to essential medicines, on average, clinics
had only about half of these medicines in stock, and 21 %
of clinics did not have availability of any of the drugs.
We also find some suggestive evidence that that demand-
side barriers such as low perceived need for services and
lack of transportation to clinics continued to play an im-
portant role (the revised iteration of the scheme sought to
address this constraint by including a conditional cash
transfer to households to encourage utilization) [11]. For
example, in our survey we asked women who gave birth at
home why they did not opt for a facility birth, and for 70 %
of births that did not take place in a health facility, the
mother reported that the reason was because it was “not
necessary”. In contrast only 4 % and <1 % of the time did
the mother give “facility not open” and “no female pro-
vider” as the reason why. This suggests that women did not
consider a facility birth to be a high priority.
This study contributes to a growing literature evaluating
the effects of policies and programs designed to increase
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Fig. 3 Program effects over time: Delivery
Table 6 Estimated effects of MSS on maternal complications
Number β (95 % CI) p-value %D
Intra-partum complications
Average effect 5295 0.012 (−0.028, 0.051) 0.556 0.250
Year 1 5295 0.003 (−0.044, 0.045) 0.912 0.063
Year 2 5295 0.014 (−0.035, 0.063) 0.577 0.292
Year 3 5295 0.020 (−0.033, 0.073) 0.466 0.417
Post-partum complications
Average effect 5295 0.002 (−0.033, 0.038) 0.891 0.048
Year 1 5295 −0.014 (−0.053, 0.024) 0.469 −0.333
Year 2 5295 0.010 (−0.038, 0.052) 0.660 0.238
Year 3 5295 0.013 (−0.037, 0.063) 0.612 0.310
β denotes the estimated effect of the MSS program, and is obtained using a
differences-in-differences specification that includes month of birth and
community fixed effects and controls for maternal and child characteristics. %D
expresses the estimated program effect as a percentage of the baseline average
of the outcome variable. Standard errors in parentheses are clustered at the
community level
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use of maternal and child health services in developing
countries. Much of this literature has focused on demand-
side initiatives such as conditional cash transfers [12, 13],
transportation subsidies [14], and voucher schemes
[15–17]; supply-side studies are considerably less com-
mon. [18] Limited availability of skilled providers, par-
ticularly in rural areas, is thought to be an important
constraint but there is little empirical research evaluating
the effects of scaling up access to providers. Frankenberg
et al. [19], one of the few examples, find weak evidence
that the village midwife programme in Indonesia increased
use of antenatal care and the likelihood of delivering with
the assistance of a medically trained provider. Fauveau et
al. [20] study a similar midwife program in Bangladesh
and find that many home births were still not attended by
midwives. The present study is largely consistent with this
work in finding small effects of the Midwifery Scheme in
Nigeria and highlights the challenge of improving maternal
and child outcomes in developing countries.
This study has several limitations. First, as the evalu-
ation was carried out ex-post it presented a number of
challenges. For example, though some data were col-
lected at baseline from MSS communities, there was no
comparison group at baseline. As such, we do not have a
baseline and follow-up in the classical sense; our birth
panel is constructed retrospectively. Our design relies on
similar trends in intervention and comparison communi-
ties, and we attempt to validate this assumption by exam-
ining trends in the pre-period. We are not able to reject
the null of similarity, but we add the caveat that we have
about 11 months of pre-data. A longer pre-period would
have been desirable, allowing for a stronger test, but
would have meant extending the recall period beyond five
years (we followed the widely used Demographic and
Health Surveys in keeping the recall period to the last five
years). If the underlying assumptions are met, then this
strategy provides robust estimates of the effect of the pro-
gram, but readers should interpret these estimates with
this caveat in mind. Second, our approach relies on retro-
spective information collected from women via a survey,
raising the potential problem of accuracy of recall. This is
unlikely to be a major concern for our primary outcomes,
antenatal care and place of birth/skilled birth attendance,
but may be a concern for delivery complications [21, 22].
If the measurement error in the dependent variable is
classical (to the extent that it is present) then the estimate
of program effects is unbiased (although the standard er-
rors would be larger), but if it is correlated with the ex-
planatory variables then the estimates may be biased [23].
Given this, the results for maternal complications (our
secondary outcome) should be interpreted cautiously.
However, we note that in developing country settings
where a large fraction of births occur outside health in-
stitutions, survey data are usually the only option as
birth registration data, where available, are notoriously
incomplete [24].
Conclusions
Poor access to skilled health providers, particularly in
rural areas, is regarded as one of the main challenges to
increasing rates of skilled birth attendance in poor coun-
tries. Given the dearth of empirical evidence, researchers
have attempted to use models to project the effects of
scale-up. Homer et al. [6], for example, estimate that a
modest increase in coverage of midwifery could poten-
tially avert 30 % of maternal deaths and half of neonatal
deaths. The results in this paper reinforce the need for
caution in generalizing from these estimates. As this evalu-
ation shows, scaling up the supply of midwives in the real
world is a complex undertaking and may not translate into
the desired outcomes. One of the lessons of this evaluation
is that increasing the supply of midwives, by itself, may not
be a sufficient condition for increasing skilled birth attend-
ance. Other interventions targeting other aspects of service
quality such as improving clinic infrastructure and ensur-
ing that clinics have adequate equipment and supplies,
strengthening incentives for health providers to deliver
high quality care, and tackling demand-side barriers will
likely prove necessary.
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